Product Recalls in Washington

Product recalls affecting Washington — including food, drugs, consumer products, medical devices, and vehicles distributed to Washington. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,773 recalls have been distributed to Washington in the last 12 months.

51,768 total recalls
2,773 in last 12 months

Showing 1300113020 of 51,768 recalls

DrugApril 27, 2022· Lupin Pharmaceuticals Inc.

Recalled Item: GaviLyte -C (Polyethylene Glycol 3350 Recalled by Lupin Pharmaceuticals Inc....

The Issue: Failed Stability Specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceApril 26, 2022· Haemonetics Corporation

Recalled Item: TEG 5000 Functional Fibrinogen Reagent Recalled by Haemonetics Corporation...

The Issue: Due to a shift in the citrated blood range for a normal population, the...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceApril 26, 2022· Beaver Visitec International, Inc.

Recalled Item: BVI Wet -Field Eraser Recalled by Beaver Visitec International, Inc. Due to...

The Issue: Boxes labeled as Wet-Field Eraser, 18GA Blunt Tip, 45Deg., were shipped...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceApril 26, 2022· Baxter Healthcare Corporation

Recalled Item: In-Line ventilator adaptor Recalled by Baxter Healthcare Corporation Due to...

The Issue: There is a potential of reduced oxygenation or pneumothorax/barotrauma to...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class I — Serious Health HazardOngoing
Medical DeviceApril 26, 2022· Baxter Healthcare Corporation

Recalled Item: In-Line ventilator adaptor Recalled by Baxter Healthcare Corporation Due to...

The Issue: There is a potential of reduced oxygenation or pneumothorax/barotrauma to...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class I — Serious Health HazardOngoing
Medical DeviceApril 26, 2022· Daavlin Distributing Company

Recalled Item: 1 Series CX phototherapy units equipped with Daavlin's ClearLink Control...

The Issue: Software issue, resuming an interrupted treatment will result in swap of...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceApril 26, 2022· Daavlin Distributing Company

Recalled Item: 4 Series CX phototherapy units equipped with Daavlin's ClearLink Control...

The Issue: Software issue, resuming an interrupted treatment will result in swap of...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugApril 25, 2022· SCA Pharmaceuticals

Recalled Item: Vancomycin HCl 1.5 g in 0.9% Sodium Chloride Recalled by SCA Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· SCA Pharmaceuticals

Recalled Item: Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bag Recalled by SCA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· SCA Pharmaceuticals

Recalled Item: Fentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bags...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules USP Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceApril 25, 2022· GE Healthcare, LLC

Recalled Item: Back up batteries in Avance CS2 and Avance CS2 Pro Recalled by GE...

The Issue: Backup batteries can fail earlier than their estimated life.

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceApril 25, 2022· GE Healthcare, LLC

Recalled Item: Field replacement back up batteries distributed on or after April 1 Recalled...

The Issue: Backup batteries can fail earlier than their estimated life.

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceApril 25, 2022· CardioTek BV

Recalled Item: CardioTek EP-TRACER Software V2.x. Recalled by CardioTek BV Due to Device...

The Issue: Device did not pass electrical safety testing for adequate insulation.

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugApril 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 10 mg Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 20 mg Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 40 mg Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceApril 22, 2022· Fresenius Kabi USA, LLC

Recalled Item: Ivenix Infusion System (IIS) Recalled by Fresenius Kabi USA, LLC Due to...

The Issue: Start-up time for the flow rate range greater than 50 ml/hr, and less than...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing